 | • レポートコード：MRC308GR11519 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のホスホジエステラーゼ-5 阻害剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のホスホジエステラーゼ-5 阻害剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ホスホジエステラーゼ-5 阻害剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ホスホジエステラーゼ-5 阻害剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・経口錠剤、経口液剤
用途別セグメント
・病院、製薬会社、研究所、クリニック、その他
主要な市場プレーヤー
・Pfizer、Eli Lilly、Baye、Dong-A Pharm、Torrent Pharmaceuticals、GSK、Abbott Laboratories、Teva Pharmaceuticals、Hetero Drugs、Zydus Cadila
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ホスホジエステラーゼ-5 阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なホスホジエステラーゼ-5 阻害剤メーカーの企業概要、2019年～2022年までのホスホジエステラーゼ-5 阻害剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なホスホジエステラーゼ-5 阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ホスホジエステラーゼ-5 阻害剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのホスホジエステラーゼ-5 阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのホスホジエステラーゼ-5 阻害剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびホスホジエステラーゼ-5 阻害剤の産業チェーンを掲載しています。
・第14、15章では、ホスホジエステラーゼ-5 阻害剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ホスホジエステラーゼ-5 阻害剤の概要
– 種類別分析（2018年vs2022年vs2029年）：経口錠剤、経口液剤
– 用途別分析（2018年vs2022年vs2029年）：病院、製薬会社、研究所、クリニック、その他
– 世界のホスホジエステラーゼ-5 阻害剤市場規模・予測
– 世界のホスホジエステラーゼ-5 阻害剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Eli Lilly、Baye、Dong-A Pharm、Torrent Pharmaceuticals、GSK、Abbott Laboratories、Teva Pharmaceuticals、Hetero Drugs、Zydus Cadila
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口錠剤、経口液剤
・用途別分析2018年-2029年：病院、製薬会社、研究所、クリニック、その他
・ホスホジエステラーゼ-5 阻害剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ホスホジエステラーゼ-5 阻害剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ホスホジエステラーゼ-5 阻害剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ホスホジエステラーゼ-5 阻害剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ホスホジエステラーゼ-5 阻害剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Phosphodiesterase-5 Inhibitor
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Phosphodiesterase-5 Inhibitor Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Tablet
1.3.3 Oral Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Phosphodiesterase-5 Inhibitor Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmaceutical Company
1.4.4 Laboratory
1.4.5 Clinic
1.4.6 Others
1.5 Global Phosphodiesterase-5 Inhibitor Market Size & Forecast
1.5.1 Global Phosphodiesterase-5 Inhibitor Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Phosphodiesterase-5 Inhibitor Sales Quantity (2018-2029)
1.5.3 Global Phosphodiesterase-5 Inhibitor Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Phosphodiesterase-5 Inhibitor Product and Services
2.1.4 Pfizer Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Phosphodiesterase-5 Inhibitor Product and Services
2.2.4 Eli Lilly Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 Baye
2.3.1 Baye Details
2.3.2 Baye Major Business
2.3.3 Baye Phosphodiesterase-5 Inhibitor Product and Services
2.3.4 Baye Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Baye Recent Developments/Updates
2.4 Dong-A Pharm
2.4.1 Dong-A Pharm Details
2.4.2 Dong-A Pharm Major Business
2.4.3 Dong-A Pharm Phosphodiesterase-5 Inhibitor Product and Services
2.4.4 Dong-A Pharm Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Dong-A Pharm Recent Developments/Updates
2.5 Torrent Pharmaceuticals
2.5.1 Torrent Pharmaceuticals Details
2.5.2 Torrent Pharmaceuticals Major Business
2.5.3 Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Product and Services
2.5.4 Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Torrent Pharmaceuticals Recent Developments/Updates
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Phosphodiesterase-5 Inhibitor Product and Services
2.6.4 GSK Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GSK Recent Developments/Updates
2.7 Abbott Laboratories
2.7.1 Abbott Laboratories Details
2.7.2 Abbott Laboratories Major Business
2.7.3 Abbott Laboratories Phosphodiesterase-5 Inhibitor Product and Services
2.7.4 Abbott Laboratories Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Abbott Laboratories Recent Developments/Updates
2.8 Teva Pharmaceuticals
2.8.1 Teva Pharmaceuticals Details
2.8.2 Teva Pharmaceuticals Major Business
2.8.3 Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Product and Services
2.8.4 Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceuticals Recent Developments/Updates
2.9 Hetero Drugs
2.9.1 Hetero Drugs Details
2.9.2 Hetero Drugs Major Business
2.9.3 Hetero Drugs Phosphodiesterase-5 Inhibitor Product and Services
2.9.4 Hetero Drugs Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hetero Drugs Recent Developments/Updates
2.10 Zydus Cadila
2.10.1 Zydus Cadila Details
2.10.2 Zydus Cadila Major Business
2.10.3 Zydus Cadila Phosphodiesterase-5 Inhibitor Product and Services
2.10.4 Zydus Cadila Phosphodiesterase-5 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zydus Cadila Recent Developments/Updates
3 Competitive Environment: Phosphodiesterase-5 Inhibitor by Manufacturer
3.1 Global Phosphodiesterase-5 Inhibitor Sales Quantity by Manufacturer (2018-2023)
3.2 Global Phosphodiesterase-5 Inhibitor Revenue by Manufacturer (2018-2023)
3.3 Global Phosphodiesterase-5 Inhibitor Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Phosphodiesterase-5 Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Phosphodiesterase-5 Inhibitor Manufacturer Market Share in 2022
3.4.2 Top 6 Phosphodiesterase-5 Inhibitor Manufacturer Market Share in 2022
3.5 Phosphodiesterase-5 Inhibitor Market: Overall Company Footprint Analysis
3.5.1 Phosphodiesterase-5 Inhibitor Market: Region Footprint
3.5.2 Phosphodiesterase-5 Inhibitor Market: Company Product Type Footprint
3.5.3 Phosphodiesterase-5 Inhibitor Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Phosphodiesterase-5 Inhibitor Market Size by Region
4.1.1 Global Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2018-2029)
4.1.2 Global Phosphodiesterase-5 Inhibitor Consumption Value by Region (2018-2029)
4.1.3 Global Phosphodiesterase-5 Inhibitor Average Price by Region (2018-2029)
4.2 North America Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029)
4.3 Europe Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029)
4.4 Asia-Pacific Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029)
4.5 South America Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029)
4.6 Middle East and Africa Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2029)
5.2 Global Phosphodiesterase-5 Inhibitor Consumption Value by Type (2018-2029)
5.3 Global Phosphodiesterase-5 Inhibitor Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2029)
6.2 Global Phosphodiesterase-5 Inhibitor Consumption Value by Application (2018-2029)
6.3 Global Phosphodiesterase-5 Inhibitor Average Price by Application (2018-2029)
7 North America
7.1 North America Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2029)
7.2 North America Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2029)
7.3 North America Phosphodiesterase-5 Inhibitor Market Size by Country
7.3.1 North America Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2018-2029)
7.3.2 North America Phosphodiesterase-5 Inhibitor Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2029)
8.2 Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2029)
8.3 Europe Phosphodiesterase-5 Inhibitor Market Size by Country
8.3.1 Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2018-2029)
8.3.2 Europe Phosphodiesterase-5 Inhibitor Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Phosphodiesterase-5 Inhibitor Market Size by Region
9.3.1 Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Phosphodiesterase-5 Inhibitor Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2029)
10.2 South America Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2029)
10.3 South America Phosphodiesterase-5 Inhibitor Market Size by Country
10.3.1 South America Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2018-2029)
10.3.2 South America Phosphodiesterase-5 Inhibitor Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Phosphodiesterase-5 Inhibitor Market Size by Country
11.3.1 Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Phosphodiesterase-5 Inhibitor Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Phosphodiesterase-5 Inhibitor Market Drivers
12.2 Phosphodiesterase-5 Inhibitor Market Restraints
12.3 Phosphodiesterase-5 Inhibitor Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Phosphodiesterase-5 Inhibitor and Key Manufacturers
13.2 Manufacturing Costs Percentage of Phosphodiesterase-5 Inhibitor
13.3 Phosphodiesterase-5 Inhibitor Production Process
13.4 Phosphodiesterase-5 Inhibitor Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Phosphodiesterase-5 Inhibitor Typical Distributors
14.3 Phosphodiesterase-5 Inhibitor Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Phosphodiesterase-5 Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Phosphodiesterase-5 Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Phosphodiesterase-5 Inhibitor Product and Services
Table 6. Pfizer Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly Phosphodiesterase-5 Inhibitor Product and Services
Table 11. Eli Lilly Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. Baye Basic Information, Manufacturing Base and Competitors
Table 14. Baye Major Business
Table 15. Baye Phosphodiesterase-5 Inhibitor Product and Services
Table 16. Baye Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Baye Recent Developments/Updates
Table 18. Dong-A Pharm Basic Information, Manufacturing Base and Competitors
Table 19. Dong-A Pharm Major Business
Table 20. Dong-A Pharm Phosphodiesterase-5 Inhibitor Product and Services
Table 21. Dong-A Pharm Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Dong-A Pharm Recent Developments/Updates
Table 23. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Torrent Pharmaceuticals Major Business
Table 25. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Product and Services
Table 26. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Torrent Pharmaceuticals Recent Developments/Updates
Table 28. GSK Basic Information, Manufacturing Base and Competitors
Table 29. GSK Major Business
Table 30. GSK Phosphodiesterase-5 Inhibitor Product and Services
Table 31. GSK Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GSK Recent Developments/Updates
Table 33. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. Abbott Laboratories Major Business
Table 35. Abbott Laboratories Phosphodiesterase-5 Inhibitor Product and Services
Table 36. Abbott Laboratories Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Abbott Laboratories Recent Developments/Updates
Table 38. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceuticals Major Business
Table 40. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Product and Services
Table 41. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceuticals Recent Developments/Updates
Table 43. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 44. Hetero Drugs Major Business
Table 45. Hetero Drugs Phosphodiesterase-5 Inhibitor Product and Services
Table 46. Hetero Drugs Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hetero Drugs Recent Developments/Updates
Table 48. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 49. Zydus Cadila Major Business
Table 50. Zydus Cadila Phosphodiesterase-5 Inhibitor Product and Services
Table 51. Zydus Cadila Phosphodiesterase-5 Inhibitor Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Zydus Cadila Recent Developments/Updates
Table 53. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Phosphodiesterase-5 Inhibitor Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Phosphodiesterase-5 Inhibitor Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Phosphodiesterase-5 Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Phosphodiesterase-5 Inhibitor Production Site of Key Manufacturer
Table 58. Phosphodiesterase-5 Inhibitor Market: Company Product Type Footprint
Table 59. Phosphodiesterase-5 Inhibitor Market: Company Product Application Footprint
Table 60. Phosphodiesterase-5 Inhibitor New Market Entrants and Barriers to Market Entry
Table 61. Phosphodiesterase-5 Inhibitor Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Phosphodiesterase-5 Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Phosphodiesterase-5 Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Phosphodiesterase-5 Inhibitor Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Phosphodiesterase-5 Inhibitor Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Phosphodiesterase-5 Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Phosphodiesterase-5 Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Phosphodiesterase-5 Inhibitor Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Phosphodiesterase-5 Inhibitor Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Phosphodiesterase-5 Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Phosphodiesterase-5 Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Phosphodiesterase-5 Inhibitor Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Phosphodiesterase-5 Inhibitor Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Phosphodiesterase-5 Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Phosphodiesterase-5 Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Phosphodiesterase-5 Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Phosphodiesterase-5 Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Phosphodiesterase-5 Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Phosphodiesterase-5 Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Phosphodiesterase-5 Inhibitor Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Phosphodiesterase-5 Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Phosphodiesterase-5 Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Phosphodiesterase-5 Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Phosphodiesterase-5 Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Phosphodiesterase-5 Inhibitor Raw Material
Table 121. Key Manufacturers of Phosphodiesterase-5 Inhibitor Raw Materials
Table 122. Phosphodiesterase-5 Inhibitor Typical Distributors
Table 123. Phosphodiesterase-5 Inhibitor Typical Customers
List of Figures
Figure 1. Phosphodiesterase-5 Inhibitor Picture
Figure 2. Global Phosphodiesterase-5 Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Type in 2022
Figure 4. Oral Tablet Examples
Figure 5. Oral Liquid Examples
Figure 6. Global Phosphodiesterase-5 Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Pharmaceutical Company Examples
Figure 10. Laboratory Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Phosphodiesterase-5 Inhibitor Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Phosphodiesterase-5 Inhibitor Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Phosphodiesterase-5 Inhibitor Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Phosphodiesterase-5 Inhibitor Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Phosphodiesterase-5 Inhibitor by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Phosphodiesterase-5 Inhibitor Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Phosphodiesterase-5 Inhibitor Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Phosphodiesterase-5 Inhibitor Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Phosphodiesterase-5 Inhibitor Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Phosphodiesterase-5 Inhibitor Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 55. China Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Phosphodiesterase-5 Inhibitor Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Phosphodiesterase-5 Inhibitor Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Phosphodiesterase-5 Inhibitor Market Drivers
Figure 76. Phosphodiesterase-5 Inhibitor Market Restraints
Figure 77. Phosphodiesterase-5 Inhibitor Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Phosphodiesterase-5 Inhibitor in 2022
Figure 80. Manufacturing Process Analysis of Phosphodiesterase-5 Inhibitor
Figure 81. Phosphodiesterase-5 Inhibitor Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source